Product category:
Genomics
News Release from: Sigma-Aldrich | Subject: GenomePlex
Edited by the Laboratorytalk Editorial
Team on 21 February 2006
Expanding position in whole genome
amplification
Sigma-Aldrich announces a new licensing agreement with Rubicon Genomics that allows Sigma to offer GenomePlex whole genome amplification (WGA) kits to service providers
Under this agreement, Sigma-Aldrich may sell GenomePlex kits to companies offering whole genome amplification services, thus expanding the service market to archived samples, FFPE and single cells Rubicon Genomics will retain all rights to WGA for molecular diagnostics, and will continue its existing service business
This article was originally published on Laboratorytalk on 12 Oct 2004 at 8.00am (UK)
Related stories
Whole genome amplification deal
Covers development of a whole genome amplification technology said to give a highly sensitive, accurate, and proprietary method of amplifying total DNA from any organism
High yield from minute quantities of genomic DNA
Whole genome amplification kit amplifies nanogram amounts of starting DNA into microgram yields in less than three hours, regardless of source
"This licensing agreement enables Sigma-Aldrich to partner with service providers that offer genetic processing capabilities and expertise," said Keith Jolliff, director of strategic marketing at Sigma-Aldrich.
"Market Research shows that 30 percent of customers are currently using service companies for WGA.
"However, service providers have been limited in their ability to amplify DNA from damaged or degraded sources, such as FFPE or archived samples, and from single cells.
"This agreement allows Sigma-Aldrich to more broadly share our enhancements of the GenomePlex technology to enable service providers to more effectively meet the needs of researchers".
In 2004 Sigma-Aldrich announced an exclusive licensing agreement with Rubicon Genomics to further develop and commercialise the GenomePlex WGA technology, a highly sensitive, accurate and proprietary method of amplifying genomic DNA from any organism.
At that time, Rubicon Genomics retained all rights to WGA for molecular diagnostics and services.
Sigma-Aldrich's success with the GenomePlex technology has led to the development of several kits that offer robust and accurate amplification.
The latest addition to the product family is the GenomePlex single cell WGA kit, which supports whole genome amplification from a single cell and results in a million-fold amplification of genomic DNA.
GenomePlex is a proprietary amplification method based on random fragmentation of the genome into a series of overlapping, short templates.
The resulting shorter DNA strands are efficiently primed and amplified to generate a library of DNA fragments with defined 3' and 5' termini, or the OmniPlex library.
This library is replicated using a linear, isothermal amplification in the initial stages, followed by a limited round of geometric (PCR) amplifications.
• Sigma-Aldrich: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
